Bora CDMO Bora CDMO

X

Find the latest Drugs in Development and Pipeline Prospector News of PENDOPHARM DIVISION OF DE PHARMASCIENCE INC.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
PENDOPHARM DIVISION OF DE PHARMASCIENCE INC
Canada Flag
Country
Country
Canada
Address
Address
6111 Royalmount Montreal, Quebec H4P 2T4
Telephone
Telephone
+514-340-9800 #7690
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

Health Canada has issued a Notice of Compliance for the prescription drug MYINFLA™ (colchicine 0.5 mg tablets) based on the results of the Montreal Heart Institute (MHI)’s COLCOT clinical trial.


Lead Product(s): Colchicine

Therapeutic Area: Cardiology/Vascular Diseases Product Name: Myinfla

Highest Development Status: ApprovedProduct Type: Small molecule

Recipient: Montreal Heart Institute

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable August 27, 2021

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY